Altimmune, Inc.

Weight-loss drug maker $ALT is making another leg up today after the CEO said it is open to deals and collaborations with large drugmakers, as it looks for partners, for its experimental obesity drug

Share this article:

About the Author:

Altimmune, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup